BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 24563633)

  • 1. Angiogenesis in spontaneous tumors and implications for comparative tumor biology.
    Benazzi C; Al-Dissi A; Chau CH; Figg WD; Sarli G; de Oliveira JT; Gärtner F
    ScientificWorldJournal; 2014; 2014():919570. PubMed ID: 24563633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor.
    Zhao Y; Adjei AA
    Oncologist; 2015 Jun; 20(6):660-73. PubMed ID: 26001391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Angiogenesis and antiangiogenic cancer therapy].
    Pour L; Hájek R; Buchler T; Maisnar V; Smolej L
    Vnitr Lek; 2004 Dec; 50(12):930-8. PubMed ID: 15717808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tumor angiogenesis: new approaches to cancer therapy].
    Marmé D
    Onkologie; 2001 Feb; 24 Suppl 1():1-5. PubMed ID: 11441305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VEGF receptor signaling in tumor angiogenesis.
    McMahon G
    Oncologist; 2000; 5 Suppl 1():3-10. PubMed ID: 10804084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiangiogenic therapies targeting the vascular endothelia growth factor signaling system.
    Tie J; Desai J
    Crit Rev Oncog; 2012; 17(1):51-67. PubMed ID: 22471664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Decade of Experience in Developing Preclinical Models of Advanced- or Early-Stage Spontaneous Metastasis to Study Antiangiogenic Drugs, Metronomic Chemotherapy, and the Tumor Microenvironment.
    Kerbel RS
    Cancer J; 2015; 21(4):274-83. PubMed ID: 26222079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The VEGF/Rho GTPase signalling pathway: a promising target for anti-angiogenic/anti-invasion therapy.
    van der Meel R; Symons MH; Kudernatsch R; Kok RJ; Schiffelers RM; Storm G; Gallagher WM; Byrne AT
    Drug Discov Today; 2011 Mar; 16(5-6):219-28. PubMed ID: 21262381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiangiogenic Effect of Flavonoids and Chalcones: An Update.
    Mirossay L; Varinská L; Mojžiš J
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29271940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. III. Angiogenesis: complexity of tumor vasculature and microenvironment.
    Furuya M; Yonemitsu Y; Aoki I
    Curr Pharm Des; 2009; 15(16):1854-67. PubMed ID: 19519428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Angiogenesis as part of the tumor "ecosystem" and possibilities to influence it].
    Klener P
    Klin Onkol; 2010; 23(1):14-20. PubMed ID: 20192069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiology of tumor neovascularization.
    Furuya M; Nishiyama M; Kasuya Y; Kimura S; Ishikura H
    Vasc Health Risk Manag; 2005; 1(4):277-90. PubMed ID: 17315600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revisiting tumor angiogenesis: vessel co-option, vessel remodeling, and cancer cell-derived vasculature formation.
    Qian CN; Tan MH; Yang JP; Cao Y
    Chin J Cancer; 2016 Jan; 35():10. PubMed ID: 26747273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular diagnosis of tumor angiogenesis and anti-angiogenic cancer therapy.
    Sato Y
    Int J Clin Oncol; 2003 Aug; 8(4):200-6. PubMed ID: 12955574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiogenesis in cancer. Basic mechanisms and therapeutic advances.
    Prager GW; Poettler M
    Hamostaseologie; 2012; 32(2):105-14. PubMed ID: 21837355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in tumor angiogenesis and malignancies.
    Pradeep CR; Sunila ES; Kuttan G
    Integr Cancer Ther; 2005 Dec; 4(4):315-21. PubMed ID: 16282508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [VEGF in neoplastic angiogenesis].
    Chekhonin VP; Shein SA; Korchagina AA; Gurina OI
    Vestn Ross Akad Med Nauk; 2012; (2):23-33. PubMed ID: 22642175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumours can adapt to anti-angiogenic therapy depending on the stromal context: lessons from endothelial cell biology.
    van Kempen LC; Leenders WP
    Eur J Cell Biol; 2006 Feb; 85(2):61-8. PubMed ID: 16439306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications.
    Ferrara N
    Semin Oncol; 2002 Dec; 29(6 Suppl 16):10-4. PubMed ID: 12516033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis.
    Hicklin DJ; Ellis LM
    J Clin Oncol; 2005 Feb; 23(5):1011-27. PubMed ID: 15585754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.